» Articles » PMID: 38046027

Long-term Follow-up of IgA Nephropathy: Clinicopathological Features and Predictors of Outcomes

Overview
Journal Clin Kidney J
Specialty Nephrology
Date 2023 Dec 4
PMID 38046027
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The establishment of the Oxford classification and newly developed prediction models have improved the prognostic information for immunoglobulin A nephropathy (IgAN). Considering new treatment options, optimizing prognostic information and improving existing prediction models are favorable.

Methods: We used random forest survival analysis to select possible predictors of end-stage kidney disease among 37 candidate variables in a cohort of 232 patients with biopsy-proven IgAN retrieved from the Norwegian Kidney Biopsy Registry. The predictive value of variables with relative importance >5% was assessed using concordance statistics and the Akaike information criterion. Pearson's correlation coefficient was used to identify correlations between the selected variables.

Results: The median follow-up period was 13.7 years. An isolated analysis of histological variables identified six variables with relative importance >5%: T %, segmental glomerular sclerosis without characteristics associated with other subtypes (not otherwise specified, NOS), normal glomeruli, global sclerotic glomeruli, segmental adherence and perihilar glomerular sclerosis. When histopathological and clinical variables were combined, estimated glomerular filtration rate (eGFR), proteinuria and serum albumin were added to the list. T % showed a better prognostic value than tubular atrophy/interstitial fibrosis (T) lesions with C-indices at 0.74 and 0.67 and was highly correlated with eGFR. Analysis of the subtypes of segmental glomerulosclerosis (S) lesions revealed that NOS and perihilar glomerular sclerosis were associated with adverse outcomes.

Conclusions: Reporting T lesions as a continuous variable, normal glomeruli and subtypes of S lesions could provide clinicians with additional prognostic information and contribute to the improved performance of the Oxford classification and prognostic tools.

Citing Articles

Lifetime progression of IgA nephropathy: a retrospective cohort study with extended long-term follow-up.

Rivedal M, Nordbo O, Haaskjold Y, Bjorneklett R, Knoop T, Eikrem O BMC Nephrol. 2025; 26(1):32.

PMID: 39833715 PMC: 11749578. DOI: 10.1186/s12882-025-03958-y.


Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning Method.

Dai Z, Chen C, Zhou Z, Zhou M, Xie Z, Liu Z J Hepatocell Carcinoma. 2024; 11:2133-2144.

PMID: 39493265 PMC: 11531708. DOI: 10.2147/JHC.S474593.


Clinical significance of glomerular IgM deposit in IgA nephropathy: a 5-year follow-up study.

Huang Z, Xu J, Ma J, Yuan C, Su Q, Chu Y Ren Fail. 2024; 46(2):2386146.

PMID: 39091091 PMC: 11299447. DOI: 10.1080/0886022X.2024.2386146.


Machine learning-based diagnosis and prognosis of IgAN: A systematic review and meta-analysis.

Zhuang K, Wang W, Xu C, Guo X, Ren X, Liang Y Heliyon. 2024; 10(12):e33090.

PMID: 38988582 PMC: 11234108. DOI: 10.1016/j.heliyon.2024.e33090.


Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group.

Oruc A, Sumnu A, Turkmen A, Basturk T, Cebeci E, Turgutalp K Ren Fail. 2024; 46(1):2341787.

PMID: 38637275 PMC: 11028022. DOI: 10.1080/0886022X.2024.2341787.


References
1.
Floege J, Rauen T, Tang S . Current treatment of IgA nephropathy. Semin Immunopathol. 2021; 43(5):717-728. PMC: 8551131. DOI: 10.1007/s00281-021-00888-3. View

2.
Maillard N, Mariat C . The Oxford Classification for immunoglobulin A nephropathy: a common language blurred by dissonant voices. Nephrol Dial Transplant. 2019; 34(10):1617-1618. DOI: 10.1093/ndt/gfz009. View

3.
Soares M, Roberts I . IgA nephropathy: an update. Curr Opin Nephrol Hypertens. 2017; 26(3):165-171. DOI: 10.1097/MNH.0000000000000312. View

4.
Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H . Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol. 2013; 8(12):2082-90. PMC: 3848397. DOI: 10.2215/CJN.03480413. View

5.
Barbour S, Coppo R, Zhang H, Liu Z, Suzuki Y, Matsuzaki K . Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. JAMA Intern Med. 2019; 179(7):942-952. PMC: 6583088. DOI: 10.1001/jamainternmed.2019.0600. View